Emiel Leegwater

Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors

Emiel Leegwater, Anne S. Strik, Erik B. Wilms et al. · Clinical Infectious Diseases · 2020 · 71 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients

Emiel Leegwater, B V C Kraaijenbrink, Dirk Jan A. R. Moes et al. · Journal of Antimicrobial Chemotherapy · 2020 · 31 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients

Emiel Leegwater, Dirk Jan A. R. Moes, Liesbeth Bosma et al. · Antimicrobial Agents and Chemotherapy · 2022 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration

Emiel Leegwater, Leo Wewerinke, Anne M. de Grauw et al. · Clinical Pharmacokinetics · 2023 · 13 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17